Testimonials
A growing number of clinicians rely on AdaptDx to detect age-related macular degeneration in their adult patients. Our customers tell the story of how they’re fighting against blindness caused by AMD.
The AdaptDx Pro is amazing for two primary reasons. One, the portability of it is phenomenal. The other piece that’s critical is that Theia, the onboard AI tech, provides the instructions for the test, so patients get consistent instruction every time.
Ryan Powell, OD
The AdaptDx Pro and Theia will change the future of AMD care because they make it easier for eye care professionals to test more patients and diagnose disease at an earlier stage.
Claudio Lagunas, OD
By being able to test more patients, we’ll ultimately uncover more macular degeneration. That’s good for patients. And I think we all need to realize is that what’s good for our patients winds up being good for our practices.
Jeffry Gerson, OD, FAAO
The AdaptDx Pro gives us the opportunity to change the future of macular degeneration care because it allows us to screen everyone at risk and identify macular degeneration earlier. The whole objective is to reduce the number of patients losing vision from macular degeneration.
Ryan Powell, OD
Screening for macular degeneration is important because as we know, once we lose sight in our macula and once it becomes affected, there’s no getting that back. So being proactive is a lot better than being reactive.
Kader Diskin, Optometry Student
The AdaptDx Pro with Theia is a huge opportunity to differentiate yourself, become more medical, and have a more successful practice as well.
Claudio Lagunas, OD
Primary eye care conquered glaucoma because they use technology that enabled them to accurately diagnose and monitor the disease.
Gregory Jackson, PhD
Dark adaptation testing has allowed me to provide care earlier for many AMD patients. Science tells that I am helping these patients years before they would have developed, clinically evident disease. Patients appreciate this more proactive approach and are very accepting of it.
Jeffry Gerson, OD, FAAO
The current standard is for us to wait around until we see macular degeneration progressing in someone’s eye. We now know we can identify it earlier, up to 3 years earlier before it ever shows up in their eye. I truly believe dark adaptation testing should be the standard of care.
Ryan Powell, OD
The AdaptDx Pro is a tool, that not only to gives you better patient outcomes, which is the most important thing, but also the ability to grow your practice. There’s a huge opportunity because AMD is more prevalent than glaucoma, diabetes and diabetic retinopathy combined.
Claudio Lagunas, OD
